EXOSC5
Exosome complex component RRP46
Also known as: EXOS5_HUMAN, hRrp46p, MGC12901, p12B, RRP41B, RRP46, Rrp46p
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NQT4
- Gene
- EXOSC5
- Ensembl
- ENSG00000077348
- Chromosome
- 19
- Canonical length
- 235 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable RNA binding activity. Involved in DNA deamination; RNA processing; and mRNA catabolic process. Acts upstream of or within defense response to virus. Located in cytosol; euchromatin; and nuclear lumen. Part of exosome (RNase complex). [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>Q9NQT4|EXOSC5
1 MEEETHTDAK IRAENGTGSS PRGPGCSLRH FACEQNLLSR PDGSASFLQG DTSVLAGVYG
61 PAEVKVSKEI FNKATLEVIL RPKIGLPGVA EKSRERLIRN TCEAVVLGTL HPRTSITVVL
121 QVVSDAGSLL ACCLNAACMA LVDAGVPMRA LFCGVACALD SDGTLVLDPT SKQEKEARAV
181 LTFALDSVER KLLMSSTKGL YSDTELQQCL AAAQAASQHV FRFYRESLQR RYSKSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EXOSC5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 45 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 45 nTPM
- pancreas: 31 nTPM
- skin: 25 nTPM
- spinal cord: 24 nTPM
- basal ganglia: 24 nTPM
- esophagus: 23 nTPM
Single-cell type
- extravillous trophoblasts: 149 nCPM
- migrating cytotrophoblasts: 94 nCPM
- esophageal basal cells: 85 nCPM
- oocytes: 74 nCPM
- differentiating spermatogonia: 65 nCPM
- esophageal suprabasal cells: 60 nCPM
Immune cell
- plasmacytoid DC: 116 nTPM
- myeloid DC: 107 nTPM
- intermediate monocyte: 75 nTPM
- naive B-cell: 72 nTPM
- classical monocyte: 66 nTPM
- memory B-cell: 65 nTPM
Brain region
- white matter: 20 nTPM
- medulla oblongata: 17 nTPM
- pons: 16 nTPM
- basal ganglia: 15 nTPM
- cerebellum: 14 nTPM
- spinal cord: 14 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about EXOSC5.
Disease | AllUniProt
Conditions EXOSC5 is implicated in, by any mechanism.
- Cerebellar ataxia, brain abnormalities, and cardiac conduction defects (CABAC) MIM:619576
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 74 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cerebellar ataxia, brain abnormalities, and cardiac conduction defects
Disease | ImmuneIEDB
Conditions an epitope on EXOSC5 was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.14
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.48
- DepMap mean gene effect
- -0.74
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- defense response to virus
- DNA deamination
- mRNA catabolic process
- nuclear mRNA surveillance
- poly(A)-dependent snoRNA 3'-end processing
- RNA catabolic process
- RNA processing
- rRNA catabolic process
- rRNA processing
- U4 snRNA 3'-end processing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EXOSC5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EXOSC5 as an antibody target. Whether an autoantibody or antibody against EXOSC5 could matter depends on whether native EXOSC5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EXOSC5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EXOSC5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...